Magnetic resonance and scintigraphy 99mTc-MIBI in the diagnosis and monitoring of therapy in multiple myeloma;Magnetická rezonance a scintigrafie 99mTc-MIBI v diagnostice a sledování terapie mnohoětného myelomu

Ceska Radiologie

Volumn 58, Issue 2, 2004, Pages 65-70

  Nekula, Josef ^a   Myslivecek M ^a   Bacovsky J ^a   Horak D ^a   Koranda, P ^a   Kaminek M ^a   Scudla V ^a   Vytrasova M ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

99mTc MIBI scintigraphy; Magnetic resonance; Multiple myeloma

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ALGORITHM; ARTICLE; CANCER REGRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE DURATION; EPIDURAL SPACE; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PELVIS RADIOGRAPHY; SCINTIGRAPHY; SPINAL CORD COMPRESSION; SPINE RADIOGRAPHY; WHOLE BODY SCINTISCANNING;

EID: 1842737544     PISSN: 12107883     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Bačovský, J., Mysliveček, M., Kamínek, M., Koranda, P., Hušák, V., Ščudla, V., Nekula, J. Value of technetium-99m-MIBI scintigraphy in multiple myeloma -useful indicator of clinical activity and extension of disease. Int. J. Hematol., 2002, 76, Suppl. I, s. 107.
2. Baur, A., Stäbler, A., Nagel, D., et al. Magnetic resonance imaging as a supplement for the clinical staging system of Duerie and Salmon? Cancer, 2002, 95, s. 1334-1345. e-mail: Andrea.Baurιkra.med.uni-muenchen.de.
3. Mysliveček, M., Bačovský, J., Kamínek, M., et al. Scintigrafie pomocí 99m-Tc-MIBI v diagnostice mnohoč etného myelomu: Senzitivní ukazatel biologické aktivity choroby. Klin. Onkol. - odesláno k publikaci.
4. Mysliveček, M., Bačovský, J., Kamínek, M., Koranda, P., Hušák, V., Ščudla, V., Nekula, J. Evaluation of different patterns of technetium-99m-MIBI uptake in patients with multiple myeloma and related gammapathies. Book of Abstracts ofFourth International Congress of the Croatian Society of Nuclear Medicine, Opatija-Croatia, 2002, s. 21.
5. Mysliveček, M., Bačovský, J., Kamínek, M., Koranda, P., Hušák, V., Ščudla, V., Nekula, J. Technetium-99m-MIBI scintigraphy in multiple myeloma: A sensitive index of biological activity of disease. Europ. J. Nucl. Med. 2002, 29, s. S241.
6. Mysliveček, M., Bačovský, J., Kamínek, M., Koranda, P., Hušák, V., Ščudla, V., Nekula, J. Evaluation of multiple myeloma with technetium-99m-MIBI scintigraphy. Wld J. Nucl. Med., 2002, 1, s. S267-268.
7. Nekula, J., Ščudla, V., Bačovský J., Bučil, J. Vyšetřování magnetickou rezonancí v diagnostice a léčbě mnohoč etného myelomu. Čes. Radiol., 1998, roč. 52, č . 5, s. 290-294.
8. Pace, L., Catalano, L., Del Vecchio, S., et al. Predictive value of technecium-99m sestamibi in patients with multiple myeloma and potential role in the follow up. Europ. J. Nucl. Med., 2001, 28, s. 304-312.
9. Vytřasová, M., Ščudla, V., Nekula, J., et al. Význam magnetické rezonance při vyšetř ení páteře u nemocných s mnohoč etným myelomem. Vnitř. Lék., 2001, roč. 47, č. 10, s. 694-698.
10. Wagasugi, S., Noguti, A., Katuda, T., et al. Potencial of 99m-Tc-MIBI for detecting bone marrow metastases. J. Nucl. Med., 2002, 43, s. 596-602.
11. Walker, R. C., Barlogi, B., Jacobson, J., et al. Prospective evaluation of 460 patients from total therapy II -identification of characteristics on baseline MRI examinations of prognostic significance - importance of focal lesions in multiple myeloma. IXth International Workshop in Multiple Myeloma, Salamanca, 2003, Suppl., s. 171. email: walkerronaldυams.edu.
12. Walker, R. C. FDG PET scanning of multiple myeloma. Society of Nuclear Medicine, New Orleans, 2003, Suppl., s. 230-236.
13. White, D., Barnes, D., McPhee, D., et al. Imaging bone disease in multiple myeloma. IXth International Workshop in Multiple Myeloma, Salamanca, 2003, Suppl., s. 170.
14. Wieler, H. J., Coleman, E. R. PET in Clinical Oncology. Darmstadt: Steinkopf Verlag, 2000.